Article info

Download PDFPDF

Extended report
Effects of golimumab, an anti-tumour necrosis factor-α human monoclonal antibody, on lipids and markers of inflammation

Authors

  1. Correspondence to Bruce W Kirkham, Rheumatology Department, Guy's and St Thomas’ NHS Foundation Trust, London SE1 9RT, UK; bruce.kirkham{at}gstt.nhs.uk
View Full Text

Citation

Kirkham BW, Wasko MC, Hsia EC, et al
Effects of golimumab, an anti-tumour necrosis factor-α human monoclonal antibody, on lipids and markers of inflammation

Publication history

  • Received May 25, 2012
  • Revised October 31, 2012
  • Accepted December 2, 2012
  • First published January 7, 2013.
Online issue publication 
December 04, 2013

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.